Read the opinions of Julie Holtzople (Astrazeneca), Jean-Marc Ferran (Qualiance) as they discuss balancing progress against perfection in clinical trial disclosure.
This whitepaper dives into fundamental questions that organizations often ask when sharing their internal process based on balancing utility and privacy. To learn more, download the whitepaper.
I understand that my personal information will be shared with the sponsor of the whitepaper, so they can contact me directly about their products or services. Please refer to the privacy policies of such sponsor(s) for more details on how your information will be used by them.